Ajizian, Medtronic’s chief medical officer of acute care and monitoring, revealed his departure on LinkedIn Thursday. The executive worked in the patient monitoring business before Medtronic ...

Medtronic faced challenges ... Next, the company had two underperforming businesses, Renal Care Solutions and Patient Monitoring & Respiratory Interventions. They were experiencing falling ...

From catheters to neurostimulators to continuous glucose monitoring ... years for Medtronic due to rising interest rates and ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Remote Patient Monitoring Devices Market is expected to reach USD 34.41 Bn by 2031, growing at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031. BURLINGAME, CALIFORNIA, UNITED ...

Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

The company recently earned U.S. clearance for a continuous glucose monitoring (CGM ... that help simplify the lives of these patients. Medtronic is one of the more prominent companies in this ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

A first-of-its-kind cardiogenic syncope service at Craigavon Area Hospital is transforming care for patients in Northern ...

Medtronic (NYSE: MDT ... From catheters to neurostimulators to continuous glucose monitoring devices, the company has a broad range of products in its portfolio, and it's routinely coming out ...